Ropes & Gray represented the underwriters in Biohaven Ltd.'s $175 million public offering of common shares. The pricing of the offering was announced in a press release on November 12 and closed on November 13.
Biohaven is a global clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing therapies to treat a broad range of rare and common diseases.
The team was led by capital markets partner Will Michener.
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.